About Nanovis
Nanovis is a Healthcare company based in Columbia City (United States) founded in 2006. Nano-technology-based spinal implants are manufactured by Nanovis. It operates in the Healthcare and Technology sectors. Nanovis has raised $26.86 million across 23 funding rounds from investors including 1st Source Bank, HHS and Global Health & Pharma. The company has 12 employees. Nanovis offers products and services including Nanovis Spine, FortiCore, and Nano FortiFix Pedicle Screw. Its focus areas include High Tech, Nanotechnology, Nanoenabled Products and Life Science. Its legal entity is NANOVIS, LLC. Its competitors include Spinal Simplicity, NanoHive and Xenix Medical; 2 of its 3 listed competitors have raised funding.
Company details
Nanovis was founded in 2006 and is based in Columbia City, United States, where operations focus on the medical device sector. Spinal implants incorporating nano-technology are produced, including deeply porous scaffolds, nano-patterned surfaces, and FortiCore interbody fusion devices. Developmental bactericidal technologies are also pursued, alongside titanium scaffolds for intervertebral spaces and inter-molded PEEK optima cores.
- Headquarters Columbia City, United States
- Employees 12
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website nanovistechnology.com
- Social LinkedIn X Facebook
- Legal Name Nanovis, Llc
- Total Equity Funding$26.86M (USD)
in 23 rounds
- Latest Funding Round$5.41M (USD), Series A
Mar 2020
- Investors1st Source Bank
& 6 more
- Employee Count12
Products & Services of Nanovis
Nanovis offers a comprehensive portfolio of products and services, including Nanovis Spine, FortiCore, and Nano FortiFix Pedicle Screw.
Technology for improving spinal implant integration and osseointegration.
Product enhancing fixation in orthopedic implants.
Screw technology for better implant stability and performance.
Funding Insights of Nanovis
Nanovis has successfully raised a total of $26.86M across 23 strategic funding rounds. The most recent funding activity was a Series A round of $5.41 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $26.86M
- Total Rounds 23
- Last Round Series A — $5.41M
- First Round $1.5M
(Jun 2008)
- Investors Count 7
Latest 10 of 23 funding rounds of Nanovis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2020 | $5.41M | Series A | – | – | – |
| Feb 2019 | Grant | – | – | ||
| Aug 2018 | $5.5M | Series A | – | – | |
| Aug 2018 | $5.5M | Series A | – | – | |
| Sep 2017 | $769,548 | Series A | – | – | – |
| Aug 2017 | $769,548 | Seed | – | – | – |
| Sep 2016 | $1.1M | Series A | – | – | – |
| Sep 2016 | $1.1M | Debt – Conventional | – | – | – |
| Dec 2015 | $750,000 | Series A | – | – | – |
| Nov 2015 | $750,000 | Seed | – | – | – |
7 investors in total: 7 institutional.
Investors in Nanovis
Nanovis has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include 1st Source Bank, HHS and Global Health & Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| ellipsis.ventures | ||||
Early-stage investments are made in diverse sectors by the firm. | elevateventures.com | Indianapolis, United States | ||
Support for technology commercialization and startup development is provided. | purduefoundry.com | West Lafayette, United States | ||
| ghp-news.com | ||||
Commercial banking services are provided throughout the United States. | 1863 | 1stsource.com | South Bend, United States | |
| commendacapital.com | ||||
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Nanovis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Nanovis
3 dated milestones of Nanovis across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Nanovis is founded.
- Funding First funding round of $1.5M.
- Funding Latest funding round, Series A, of $5.4M.
Competitors of Nanovis
Nanovis has 3 listed competitors in our database, 2 of them funded. They include Spinal Simplicity, NanoHive and Xenix Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| spinalsimplicity.com | 2008 | Lenexa, United States | $15.21M | 44 | Minimally invasive devices for spinal conditions are developed. | |
| nanohive.com | 2014 | Woburn, United States | $7M | 15 | Developer of spinal interbody fusion implants | |
| xenixmedical.com | 2016 | Orlando, United States | Develops innovative medical devices for spinal fusion surgery procedures. |
Detailed competitors of Nanovis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
3 companies that operate in the same segment as Nanovis (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nanovis
Complete news archive for Nanovis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nanovis
Nanovis was founded in 2006 and raised its 1st funding round 2 years after it was founded.
Nanovis is headquartered in Columbia City, United States. It is registered at Columbia City, Oregon, United States.
Nanovis is a funded company, having raised a total of $26.86M across 23 funding rounds to date. The company's 1st funding round was a Seed of $750K, raised on Jun 2008.
Nanovis has 12 employees.
Nanovis was founded in 2006 and is based in Columbia City, United States, where operations focus on the medical device sector. Spinal implants incorporating nano-technology are produced, including deeply porous scaffolds, nano-patterned surfaces, and FortiCore interbody fusion devices. Developmental bactericidal technologies are also pursued, alongside titanium scaffolds for intervertebral spaces and inter-molded PEEK optima cores.
Nanovis's top competitors include Spinal Simplicity, NanoHive and Xenix Medical.
Nanovis offers Nanovis Spine, FortiCore, and Nano FortiFix Pedicle Screw.
Nanovis has 7 investors. Key investors include 1st Source Bank, HHS, Global Health & Pharma, Ellipsis Ventures, and Commenda Capital.
Nanovis operates through Nanovis, Llc.